Lamotrigine for acute and chronic pain

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Wiffen, Philip ^a   Rees, J ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Acute disease; Analgesics *therapeutic use ; Anticonvulsants *therapeutic use ; Chronic disease; Humans; Pain *drug therapy ; Randomized controlled trials as topic; Triazines *therapeutic use

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; PLACEBO; PREGABALIN;

ACUTE DISEASE; ANALGESIA; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DISEASE COURSE; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROPATHIC PAIN; NEUROPATHY; PAIN THRESHOLD; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; RISK FACTOR; SPINAL CORD INJURY; STROKE; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

EID: 36148929888     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006044.pub2     Document Type: Review

References (33)

1. Eisenberg 2001 {published data only} Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57(3):505-9.
2. Finnerup 2002 {published data only} Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002;96(3):375-83.
3. McCleane 1999 {published data only} McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain 1999;83(1):105-7.
4. Simpson 2000 {published data only} Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000;54(11):2115-9.
5. Simpson 2003 {published data only} Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, et al.Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003;60(9):1508-14.
6. Vestergaard 2001 {published data only} Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001;56(2):184-90.
7. Zakrzewska 1997 {published data only} Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997;73(2):223-30.
8. Bonicalzi 1997b Bonicalzi V, Canavero S, Cerutti F, Piazza M, Clemente M, Chio A. Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study. Surgery 1997;122(3):567-70.
9. Carrieri 1998 Carrieri PB, Provitera V V, Lavorgna L, Bruno R. Response of thalamic pain syndrome to lamotrigine. European Journal of Neurology 1998;5(6):625-6.
10. Devulder 2000 Devulder J, De Laat M. Lamotrigine in the treatment of chronic refractory neuropathic pain. Journal of Pain Symptom Management 2000;19(5):398-403.
11. di Vadi 1998 di Vadi PP, Hamann W. The use of lamotrigine in neuropathic pain. Anaesthesia 1998;53(8):808-9.
12. Eisenberg 1998 Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitsky D. Lamotrigine in the treatment of painful diabetic neuropathy. European Journal of Neurology 1998;5(2):167-73.
13. Eisenberg 2003 Eisenberg E, Damunni G, Hoffer E, Baum Y, Krivoy N. Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia. European Journal of Pain 2003;7(6):485-91.
14. Lunardi 1997 Lunardi G, Leandri M, Albano C, Cultrera S, Fracassi M, Rubino V, Favale E. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997;48(6):1714-7.
15. Petersen 2003 Petersen KL, Maloney A, Hoke F, Dahl JB, Rowbotham MC. A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. Journal of Pain 2003;4(7):400-6.
16. Sandner-Kiesling2002 Sandner-Kiesling A, Rumpold Seitlinger G, Dorn C, Koch H, Schwarz G. Lamotrigine monotherapy for control of neuralgia after nerve section. Acta Anaesthesiologie Scand 2002;46(10):1261- 4.
17. Backonja 2002 Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59 (5 Suppl 2):S14-17.
18. Bonicalzi 1997 Bonicalzi V, Canavero S, Cerutti F, Piazza M, Clemente M, Chio A. Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study. Surgery 1997;122(3):567-70.
19. Breivik 2006 Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, characteristics and mechanisms. European Journal of Pain 2006;10(4):287-333.
20. Hall 2006 Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122:156-62.
21. Hirsch 2006 Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M, Resor SR Jr. Predictors of lamotrigine-associated rash. Epilepsia 2006;47(2):318-22.
22. Jacox 1994 Jacox A, Carr DB, Payne R. Management of cancer pain. Clinical Practice Guideline No. 9. Agency for Health Care Policy and Research. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, 1994.
23. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
24. Katusic 1991 Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984. Neuroepidemiology 1991;10:276-81.
25. McCleane 2000 McCleane GJ. Lamotrigine in the management of neuropathic pain. The Clinical Journal of Pain 2000;16:321-6.
26. McQuay 1998 McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
27. Monks 1994 Monks R. Psychotropic drugs. Wall PD, Melzack R, editor(s).Textbook of Pain. Churchill Livingstone, 1994:963-89.
28. Pain in Europe 2004 Fricker J. Pain in Europe. A report. Accessed on line at www.painineurope.com Feb 2006, 2004.
29. Rappaport 1994 Rappaport ZH, Devor M. Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 1994;56:127-38.
30. SPC 2007 Summary of product characteristics for Lamictal. Section 4.8. www.medicines.org.uk Accessed 5.2.2007.
31. Wiffen 2005a Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD001133. DOI:10.1002/ 14651858.CD001133.pub2.
32. Wiffen 2005b Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD005451. DOI:10.1002/14651858.CD005451.
33. Wiffen 2005c Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art.No.: CD005452. DOI:10.1002/14651858.CD005452.